Skip to main content
Top
Published in: PharmacoEconomics 2/2017

01-02-2017 | Practical Application

Emergent Challenges in Determining Costs for Economic Evaluations

Authors: Josephine C. Jacobs, Paul G. Barnett

Published in: PharmacoEconomics | Issue 2/2017

Login to get access

Abstract

This paper describes methods of determining costs for economic evaluations of healthcare and considers how cost determination is being affected by recent developments in healthcare. The literature was reviewed to identify the strengths and weaknesses of the four principal methods of cost determination: micro-costing, activity-based costing, charge-based costing, and gross costing. A scoping review was conducted to identify key trends in healthcare delivery and to identify costing issues associated with these changes. Existing guidelines provide information on how to implement various costing methods. Bottom-up costing is needed when accuracy is paramount, but top-down approaches are often the only feasible approach. We describe six healthcare trends that have important implications for costing methodology: (1) reform in payment mechanisms; (2) care delivery in less restrictive settings; (3) the growth of telehealth interventions; (4) the proliferation of new technology; (5) patient privacy concerns; and (6) growing efforts to implement guidelines. Some costs are difficult to measure and have been overlooked. These include physician services for inpatients, facility costs for outpatient services, the cost of developing treatment innovations, patient and caregiver costs, and the indirect costs of organizational interventions. Standardized methods are needed to determine social welfare and productivity costs. In the future, cost determination will be facilitated by technological advances but hindered by the shift to capitated payment, to the provision of care in less restrictive settings, and by heightened concern for medical record privacy.
Literature
1.
go back to reference Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
2.
go back to reference Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005. Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.
3.
go back to reference Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices–budget impact analysis. Value Health. 2007;10(5):336–47.CrossRefPubMed Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices–budget impact analysis. Value Health. 2007;10(5):336–47.CrossRefPubMed
4.
go back to reference Adam T, Koopmanschap MA, Evans DB. Cost-effectiveness analysis: can we reduce variability in costing methods? Int J Technol Assess Health Care. 2003;19(2):407–20.CrossRefPubMed Adam T, Koopmanschap MA, Evans DB. Cost-effectiveness analysis: can we reduce variability in costing methods? Int J Technol Assess Health Care. 2003;19(2):407–20.CrossRefPubMed
5.
go back to reference Smith MW, Barnett PG. Direct measurement of health care costs. Med Care Res Rev. 2003;60(3 Suppl):74S–91S.CrossRefPubMed Smith MW, Barnett PG. Direct measurement of health care costs. Med Care Res Rev. 2003;60(3 Suppl):74S–91S.CrossRefPubMed
6.
go back to reference Findorff MJ, Wyman JF, Croghan CF, Nyman JA. Use of time studies for determining intervention costs. Nurs Res. 2005;54(4):280–4 (pii:00006199-200507000-00011).CrossRefPubMed Findorff MJ, Wyman JF, Croghan CF, Nyman JA. Use of time studies for determining intervention costs. Nurs Res. 2005;54(4):280–4 (pii:00006199-200507000-00011).CrossRefPubMed
7.
go back to reference Johnston K, Buxton MJ, Jones DR, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess. 1999;3(6):1–76.PubMed Johnston K, Buxton MJ, Jones DR, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess. 1999;3(6):1–76.PubMed
11.
go back to reference Ross TK. Analyzing health care operations using ABC. J Health Care Finance. 2004;30(3):1–20.PubMed Ross TK. Analyzing health care operations using ABC. J Health Care Finance. 2004;30(3):1–20.PubMed
12.
go back to reference Udpa S. Activity-based costing for hospitals. Health Care Manag Rev. 1996;21(3):83–96.CrossRef Udpa S. Activity-based costing for hospitals. Health Care Manag Rev. 1996;21(3):83–96.CrossRef
13.
go back to reference Kaplan RS, Anderson SR. Time-driven activity-based costing. Harv Bus Rev. 2004;82(11):131–8, 50. Kaplan RS, Anderson SR. Time-driven activity-based costing. Harv Bus Rev. 2004;82(11):131–8, 50.
14.
go back to reference Udpa S. Activity cost analysis: a tool to cost medical services and improve quality of care. Manag Care Q. 2001;9(3):34–41.PubMed Udpa S. Activity cost analysis: a tool to cost medical services and improve quality of care. Manag Care Q. 2001;9(3):34–41.PubMed
15.
go back to reference Young DW. The folly of using RCCs and RVUs for intermediate product costing. Healthc Financ Manag. 2007;61(4):100–6, 8. Young DW. The folly of using RCCs and RVUs for intermediate product costing. Healthc Financ Manag. 2007;61(4):100–6, 8.
16.
go back to reference Kaplan RS, Witkowski M, Abbott M, Guzman AB, Higgins LD, Meara JG, et al. Using time-driven activity-based costing to identify value improvement opportunities in healthcare. J Healthc Manag. 2014;59(6):399–412.PubMed Kaplan RS, Witkowski M, Abbott M, Guzman AB, Higgins LD, Meara JG, et al. Using time-driven activity-based costing to identify value improvement opportunities in healthcare. J Healthc Manag. 2014;59(6):399–412.PubMed
17.
go back to reference Hunkeler EM, Hung YY, Rice DP, Weisner C, Hu T. Alcohol consumption patterns and health care costs in an HMO. Drug Alcohol Depend. 2001;64(2):181–90 (pii:S0376871601001193).CrossRefPubMed Hunkeler EM, Hung YY, Rice DP, Weisner C, Hu T. Alcohol consumption patterns and health care costs in an HMO. Drug Alcohol Depend. 2001;64(2):181–90 (pii:S0376871601001193).CrossRefPubMed
19.
go back to reference Barnett PG, Rodgers JH. Use of the Decision Support System for VA cost-effectiveness research. Med Care. 1999;37(4 Suppl Va):AS63–70. Barnett PG, Rodgers JH. Use of the Decision Support System for VA cost-effectiveness research. Med Care. 1999;37(4 Suppl Va):AS63–70.
20.
go back to reference Hill NT, Johns EL. Adoption of costing systems by U.S. hospitals. Hosp Health Serv Adm. 1994;39(4):521–37. Hill NT, Johns EL. Adoption of costing systems by U.S. hospitals. Hosp Health Serv Adm. 1994;39(4):521–37.
21.
go back to reference Gehlert E, Jacobs JC, Barnett PG. Technical Report 32: costing methods used in VA research, 1980–2012. Menlo Park: VA Palo Alto, Health Economics Resource Center; 2016. Gehlert E, Jacobs JC, Barnett PG. Technical Report 32: costing methods used in VA research, 1980–2012. Menlo Park: VA Palo Alto, Health Economics Resource Center; 2016.
22.
go back to reference Taira DA, Seto TB, Siegrist R, Cosgrove R, Berezin R, Cohen DJ. Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials. Am Heart J. 2003;145(3):452–8.CrossRefPubMed Taira DA, Seto TB, Siegrist R, Cosgrove R, Berezin R, Cohen DJ. Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials. Am Heart J. 2003;145(3):452–8.CrossRefPubMed
23.
24.
go back to reference Riley GF. Administrative and claims records as sources of health care cost data. Med Care. 2009; 47(7 Suppl 1):S51–55. Riley GF. Administrative and claims records as sources of health care cost data. Med Care. 2009; 47(7 Suppl 1):S51–55.
26.
go back to reference Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry. 1995;32(4):476–81.PubMed Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry. 1995;32(4):476–81.PubMed
27.
go back to reference Phibbs CS, Bhandari A, Yu W, Barnett PG. Estimating the costs of VA ambulatory care. Med Care Res Rev. 2003;60(3 Suppl):54S–73S.CrossRefPubMed Phibbs CS, Bhandari A, Yu W, Barnett PG. Estimating the costs of VA ambulatory care. Med Care Res Rev. 2003;60(3 Suppl):54S–73S.CrossRefPubMed
30.
go back to reference Barnett PG. Research without billing data. Econometric estimation of patient-specific costs. Med Care. 1997;35(6):553–63.CrossRefPubMed Barnett PG. Research without billing data. Econometric estimation of patient-specific costs. Med Care. 1997;35(6):553–63.CrossRefPubMed
32.
33.
go back to reference Hardy KM, Kwong J, Pitzul KB, Vergis AS, Jackson TD, Urbach DR, et al. A cost comparison of laparoscopic and open colon surgery in a publicly funded academic institution. Surg Endosc. 2014;28(4):1213–22. doi:10.1007/s00464-013-3311-y.CrossRefPubMed Hardy KM, Kwong J, Pitzul KB, Vergis AS, Jackson TD, Urbach DR, et al. A cost comparison of laparoscopic and open colon surgery in a publicly funded academic institution. Surg Endosc. 2014;28(4):1213–22. doi:10.​1007/​s00464-013-3311-y.CrossRefPubMed
35.
go back to reference Olsson TM. Comparing top-down and bottom-up costing approaches for economic evaluation within social welfare. Eur J Health Econ. 2011;12(5):9.CrossRef Olsson TM. Comparing top-down and bottom-up costing approaches for economic evaluation within social welfare. Eur J Health Econ. 2011;12(5):9.CrossRef
36.
go back to reference Mogyorosy Z, Smith P. The main methodological issues in costing health care services: a literature review. York: University of York, Center for Health Economics; 2005. Mogyorosy Z, Smith P. The main methodological issues in costing health care services: a literature review. York: University of York, Center for Health Economics; 2005.
39.
go back to reference Institute ECRI. Agency for Healthcare Research and Quality Healthcare Horizon Scanning System: Horizon Scanning Protocol and Operations Manual. Rockville: AHRQ; 2015. Institute ECRI. Agency for Healthcare Research and Quality Healthcare Horizon Scanning System: Horizon Scanning Protocol and Operations Manual. Rockville: AHRQ; 2015.
41.
go back to reference Struijs JN, Mohnen SM, Molema CCM, de Jong-VanTil JT, Baan CA. Effects of bundled payment on curative health care costs in the Netherlands: an analysis for diabetes care and vascular risk management based on nationwide claim data, 2007–2010. Bilthoven: National Institute for Public Health and the Environment; 2012. Struijs JN, Mohnen SM, Molema CCM, de Jong-VanTil JT, Baan CA. Effects of bundled payment on curative health care costs in the Netherlands: an analysis for diabetes care and vascular risk management based on nationwide claim data, 2007–2010. Bilthoven: National Institute for Public Health and the Environment; 2012.
42.
go back to reference Lix LM, Yao X, Kephart G, Quan H, Smith M, Kuwornu JP, et al. A prediction model to estimate completeness of electronic physician claims databases. BMJ Open. 2015;5(e006858):8. doi:10.1136/bmjopen-2014-006858. Lix LM, Yao X, Kephart G, Quan H, Smith M, Kuwornu JP, et al. A prediction model to estimate completeness of electronic physician claims databases. BMJ Open. 2015;5(e006858):8. doi:10.​1136/​bmjopen-2014-006858.
43.
go back to reference Alshammari AM, Hux JE. The impact of non-fee-for-service reimbursement on chronic disease surveillance using administrative data. Can J Public Health. 2009;100(6):3. Alshammari AM, Hux JE. The impact of non-fee-for-service reimbursement on chronic disease surveillance using administrative data. Can J Public Health. 2009;100(6):3.
45.
go back to reference Hilsenrath P, Eakin C, Fischer K. Price-transparency and cost accounting: challenges for health care organizations in the consumer-driven era. Inquiry. 2015;52. doi:10.1177/0046958015574981. Hilsenrath P, Eakin C, Fischer K. Price-transparency and cost accounting: challenges for health care organizations in the consumer-driven era. Inquiry. 2015;52. doi:10.​1177/​0046958015574981​.
46.
go back to reference Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat 13. 2011;(169):1–38. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat 13. 2011;(169):1–38.
47.
go back to reference Eiken S, Sredl K, Burwell B, Saucier P. Medicaid expenditures for long-term services and supports (LTSS) in FY 2013: home and community-based services were a majority of LTSS spending. Washington, DC: Medicaid.gov; 2015. Eiken S, Sredl K, Burwell B, Saucier P. Medicaid expenditures for long-term services and supports (LTSS) in FY 2013: home and community-based services were a majority of LTSS spending. Washington, DC: Medicaid.gov; 2015.
56.
go back to reference Koopmanschap MA, van Exel JN, van den Berg B, Brouwer WB. An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics. 2008;26(4):269–80.CrossRefPubMed Koopmanschap MA, van Exel JN, van den Berg B, Brouwer WB. An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics. 2008;26(4):269–80.CrossRefPubMed
64.
67.
go back to reference Gunn PP, Fremont AM, Bottrell M, Shugarman LR, Galegher J, Bikson T. The health insurance portability and accountability act privacy rule: a practical guide for researchers. Med Care. 2004;42(4):321–7 (pii:00005650-200404000-00004).CrossRefPubMed Gunn PP, Fremont AM, Bottrell M, Shugarman LR, Galegher J, Bikson T. The health insurance portability and accountability act privacy rule: a practical guide for researchers. Med Care. 2004;42(4):321–7 (pii:00005650-200404000-00004).CrossRefPubMed
68.
go back to reference Shen JJ, Samson LF, Washington EL, Johnson P, Edwards C, Malone A. Barriers of HIPAA regulation to implementation of health services research. J Med Syst. 2006;30(1):65–9.CrossRefPubMed Shen JJ, Samson LF, Washington EL, Johnson P, Edwards C, Malone A. Barriers of HIPAA regulation to implementation of health services research. J Med Syst. 2006;30(1):65–9.CrossRefPubMed
69.
go back to reference Hussey PS, Anderson GF, Osborn R, Feek C, McLaughlin V, Millar J, et al. How does the quality of care compare in five countries? Health Aff (Millwood). 2004;23(3):89–99.CrossRefPubMed Hussey PS, Anderson GF, Osborn R, Feek C, McLaughlin V, Millar J, et al. How does the quality of care compare in five countries? Health Aff (Millwood). 2004;23(3):89–99.CrossRefPubMed
70.
72.
go back to reference Principal Investigators CTSA, Shamoon H, Center D, Davis P, Tuchman M, Ginsberg H, et al. Preparedness of the CTSA’s structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci. 2012;5(2):121–9. doi:10.1111/j.1752-8062.2012.00401.x.CrossRef Principal Investigators CTSA, Shamoon H, Center D, Davis P, Tuchman M, Ginsberg H, et al. Preparedness of the CTSA’s structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci. 2012;5(2):121–9. doi:10.​1111/​j.​1752-8062.​2012.​00401.​x.CrossRef
73..
go back to reference Demakis JG, McQueen L, Kizer KW, Feussner JR. Quality Enhancement Research Initiative (QUERI): a collaboration between research and clinical practice. Med Care. 2000;38(6 Suppl 1):I17–25.PubMed Demakis JG, McQueen L, Kizer KW, Feussner JR. Quality Enhancement Research Initiative (QUERI): a collaboration between research and clinical practice. Med Care. 2000;38(6 Suppl 1):I17–25.PubMed
74.
go back to reference Hoomans T, Evers SM, Ament AJ, Hubben MW, van der Weijden T, Grimshaw JM, et al. The methodological quality of economic evaluations of guideline implementation into clinical practice: a systematic review of empiric studies. Value Health. 2007;10(4):305–16. doi:10.1111/j.1524-4733.2007.00175.x.CrossRefPubMed Hoomans T, Evers SM, Ament AJ, Hubben MW, van der Weijden T, Grimshaw JM, et al. The methodological quality of economic evaluations of guideline implementation into clinical practice: a systematic review of empiric studies. Value Health. 2007;10(4):305–16. doi:10.​1111/​j.​1524-4733.​2007.​00175.​x.CrossRefPubMed
76.
79.
go back to reference Sathe NA, Nocon RS, Hughes B, Peek ME, Chin MH, Huang ES. The costs of participating in a diabetes quality improvement collaborative: variation among five clinics. Jt Comm J Qual Patient Saf. 2016;42(1):18–25.CrossRefPubMedPubMedCentral Sathe NA, Nocon RS, Hughes B, Peek ME, Chin MH, Huang ES. The costs of participating in a diabetes quality improvement collaborative: variation among five clinics. Jt Comm J Qual Patient Saf. 2016;42(1):18–25.CrossRefPubMedPubMedCentral
80.
go back to reference Mason J, Freemantle N, Nazareth I, Eccles M, Haines A, Drummond M. When is it cost-effective to change the behavior of health professionals? JAMA. 2001;286(23):2988–92 (pii:jsc10303).CrossRefPubMed Mason J, Freemantle N, Nazareth I, Eccles M, Haines A, Drummond M. When is it cost-effective to change the behavior of health professionals? JAMA. 2001;286(23):2988–92 (pii:jsc10303).CrossRefPubMed
Metadata
Title
Emergent Challenges in Determining Costs for Economic Evaluations
Authors
Josephine C. Jacobs
Paul G. Barnett
Publication date
01-02-2017
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 2/2017
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.1007/s40273-016-0465-1

Other articles of this Issue 2/2017

PharmacoEconomics 2/2017 Go to the issue